2022
DOI: 10.1038/s41598-022-24960-6
|View full text |Cite
|
Sign up to set email alerts
|

Exome variants associated with asthma and allergy

Matthias Wjst

Abstract: The mutational spectrum of asthma and allergy associated genes is not known although recent biobank based exome sequencing studies included these traits. We therefore conducted a secondary analysis of exome data from 281,104 UK Biobank samples for association of mostly rare variants with asthma, allergic rhinitis and atopic dermatitis. Variants of interest (VOI) were tabulated, shared genes annotated and compared to earlier genome-wide SNP association studies (GWAS), whole genome sequencing, exome and bisulfit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 53 publications
0
6
0
Order By: Relevance
“…Among the upregulated genes in Mo/Ma were CXCL13 , a B‐cell chemoattractant, OLFM4 , associated with severe lung disease in humans [44, 45], and CHI3L1 , a marker of neutrophilic asthma (Figure 5d) [21]. S100A8 , known for its increased expression in individuals with steroid‐resistant neutrophilic asthma [46], was upregulated, and so was TLR1 , recently identified as a potential therapeutic target for asthma in humans (Figure 5d) [47].…”
Section: Resultsmentioning
confidence: 99%
“…Among the upregulated genes in Mo/Ma were CXCL13 , a B‐cell chemoattractant, OLFM4 , associated with severe lung disease in humans [44, 45], and CHI3L1 , a marker of neutrophilic asthma (Figure 5d) [21]. S100A8 , known for its increased expression in individuals with steroid‐resistant neutrophilic asthma [46], was upregulated, and so was TLR1 , recently identified as a potential therapeutic target for asthma in humans (Figure 5d) [47].…”
Section: Resultsmentioning
confidence: 99%
“…A recent study demonstrated that genetic variations in IL1RL1 are strongly associated with asthma, revealing that IL1RL1 acts as an essential driver of type 2 immune responses to IL-33 [ 29 ]. Moreover, IL1RL1 is a reliable marker of Th2 lymphocytes in AR, and IL1RL1 variants (e.g., rs72823628, rs950881, and rs3771175) are associated with AR risk [ 19 , 30 , 31 ]. However, in this study, the association of these variants and others between AR1 and AR2 was not identified, which is a limitation of this study and should be confirmed in the near future.…”
Section: Discussionmentioning
confidence: 99%
“…Among the upregulated genes in Mo/Ma were CXCL13, a B-cell chemoattractant, OLFM4, associated with severe lung disease in humans [44,45], and CHI3L1, a marker of neutrophilic asthma (Figure 5d) [21]. S100A8, known for its increased expression in individuals with steroid-resistant neutrophilic asthma [46], was upregulated, and so was TLR1, recently identified as a potential therapeutic target for asthma in humans (Figure 5d) [47].…”
Section: Genes Associated With T-cell Function Are Dysregulated In Seamentioning
confidence: 99%